Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment

We aimed to investigate the dynamic changes of gene expression profiles and immune microenvironment linked to resistance to cetuximab-based treatments in patients with metastatic colorectal cancer (mCRC). A total of 106 patients with RAS-wild type mCRC who were treated with cetuximab-based treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung-Don, Kim, Sun Young, Kim, Jihun, Kim, Jeong Eun, Hong, Yong Sang, Han, Buhm, Tak, Eunyoung, Ryu, Yeon-Mi, Kim, Sang-Yeob, Kim, Tae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803829/
https://www.ncbi.nlm.nih.gov/pubmed/35102212
http://dx.doi.org/10.1038/s41598-022-05694-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803829/
https://www.ncbi.nlm.nih.gov/pubmed/35102212
http://dx.doi.org/10.1038/s41598-022-05694-x

Ejemplares similares